Dolby Laboratories (NYSE:DLB) Updates FY 2025 Earnings Guidance

Dolby Laboratories (NYSE:DLB) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 3.990-4.140 for the period, compared to the consensus estimate of 4.060. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion. Dolby Laboratories also updated its Q2 2025 guidance to 1.190-1.340 EPS.

Dolby Laboratories Trading Up 8.8 %

NYSE DLB traded up $7.10 during midday trading on Thursday, hitting $87.73. The company had a trading volume of 180,088 shares, compared to its average volume of 435,043. The firm has a 50-day moving average price of $79.15 and a 200-day moving average price of $75.65. The company has a market capitalization of $8.37 billion, a PE ratio of 32.34 and a beta of 0.98. Dolby Laboratories has a twelve month low of $66.35 and a twelve month high of $88.11.

Dolby Laboratories Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 10th. Investors of record on Tuesday, December 3rd were given a dividend of $0.33 per share. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Tuesday, December 3rd. This represents a $1.32 annualized dividend and a yield of 1.50%. Dolby Laboratories’s dividend payout ratio is currently 48.71%.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the stock. Barrington Research restated an “outperform” rating and issued a $100.00 target price on shares of Dolby Laboratories in a research report on Monday. Rosenblatt Securities restated a “buy” rating and set a $100.00 target price on shares of Dolby Laboratories in a research note on Thursday. Finally, StockNews.com upgraded Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, December 4th.

Insider Activity

In other news, SVP John D. Couling sold 50,000 shares of Dolby Laboratories stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $80.04, for a total transaction of $4,002,000.00. Following the sale, the senior vice president now directly owns 106,806 shares of the company’s stock, valued at approximately $8,548,752.24. This trade represents a 31.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CAO Ryan Nicholson sold 10,500 shares of the company’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $80.18, for a total value of $841,890.00. Following the completion of the transaction, the chief accounting officer now directly owns 24,364 shares of the company’s stock, valued at $1,953,505.52. This represents a 30.12 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 135,917 shares of company stock worth $10,877,739. Corporate insiders own 38.39% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.